Barclays
NAUT icon

Barclays’s Nautilus Biotechnolgy NAUT Stock Holding History

Barclays’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$285K Buy
73,325
+25,071
+52% +$61.6K ﹤0.01% 3497
2025
Q4 		$94.1K Hold
48,254
– – ﹤0.01% 4599
2025
Q3 		$40.8K Sell
48,254
-9,835
-17% -$7.23K ﹤0.01% 4813
2025
Q2 		$42.1K Sell
58,089
-42,878
-42% -$32.2K ﹤0.01% 4728
2025
Q1 		$86.9K Sell
100,967
-24,237
-19% -$36K ﹤0.01% 4456
2024
Q4 		$210K Buy
125,204
+19,030
+18% +$45.5K ﹤0.01% 4284
2024
Q3 		$303K Buy
106,174
+47,059
+80% +$122K ﹤0.01% 4086
2024
Q2 		$138K Sell
59,115
-17,979
-23% -$46.9K ﹤0.01% 3754
2024
Q1 		$227K Sell
77,094
-33,844
-31% -$96K ﹤0.01% 4053
2023
Q4 		$332K Buy
110,938
+60,392
+119% +$173K ﹤0.01% 4142
2023
Q3 		$160K Sell
50,546
-1,040
-2% -$3.38K ﹤0.01% 3396
2023
Q2 		$200K Sell
51,586
-14,456
-22% -$41.6K ﹤0.01% 3240
2023
Q1 		$183K Buy
66,042
+11,727
+22% +$24.6K ﹤0.01% 3847
2022
Q4 		$97.8K Buy
54,315
+10,778
+25% +$20.8K ﹤0.01% 4235
2022
Q3 		$92K Sell
43,537
-371
-0.8% -$933 ﹤0.01% 3568
2022
Q2 		$118K Buy
43,908
+2,392
+6% +$8.9K ﹤0.01% 3696
2022
Q1 		$180K Buy
+41,516
New +$170K ﹤0.01% 3487

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Barclays's NAUT Position: Q1 2026 in Review

Barclays increased its Nautilus Biotechnolgy (NAUT) stake by 52% in Q1 2026, buying an estimated $61.6K and bringing the position to 73,325 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3497.

Barclays first reported a position in NAUT in Q1 2022 and has held it in 17 quarters since. The position peaked at $332K in Q4 2023. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Barclays held 73,325 shares of Nautilus Biotechnolgy worth $285K as of Q1 2026.
  • Barclays bought 25,071 Nautilus Biotechnolgy shares in Q1 2026, an estimated $61.6K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3497 holding.
  • Barclays first reported a position in Nautilus Biotechnolgy in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Nautilus Biotechnolgy position peaked at $332K in Q4 2023.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.